Galantamine versus risperidone for agitation in people with dementia: a randomized, twelve-week, single-center study.
about
Agitation in dementia: relation to core cerebrospinal fluid biomarker levels.Progresses in treating agitation: a major clinical challenge in Alzheimer's disease.Use of Antipsychotics for the Treatment of Behavioral Symptoms of Dementia.Pharmacological treatments for alleviating agitation in dementia: A systematic review and network meta-analysis.
P2860
Galantamine versus risperidone for agitation in people with dementia: a randomized, twelve-week, single-center study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Galantamine versus risperidone ...... lve-week, single-center study.
@en
Galantamine versus risperidone ...... lve-week, single-center study.
@nl
type
label
Galantamine versus risperidone ...... lve-week, single-center study.
@en
Galantamine versus risperidone ...... lve-week, single-center study.
@nl
prefLabel
Galantamine versus risperidone ...... lve-week, single-center study.
@en
Galantamine versus risperidone ...... lve-week, single-center study.
@nl
P2093
P356
P1476
Galantamine versus risperidone ...... lve-week, single-center study.
@en
P2093
Ann Christine Tysen Bäckström
Bjørn Auestad
Marie Lärksäter
Victor Bloniecki
P304
P356
10.1159/000362204
P577
2014-06-25T00:00:00Z